Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Functional Characterization of RAD51 Paralog Cancer Associated Variants of Unknown Significance

Rein, Hayley (2024) Functional Characterization of RAD51 Paralog Cancer Associated Variants of Unknown Significance. Doctoral Dissertation, University of Pittsburgh. (Unpublished)

This is the latest version of this item.

[img] PDF (Biorender Publishing License)
Supplemental Material
Restricted to University of Pittsburgh users only until 16 September 2026.

Download (2MB) | Request a Copy
[img] PDF (Updated ETD)
Primary Text
Restricted to University of Pittsburgh users only until 16 September 2026.

Download (46MB) | Request a Copy

Abstract

For many individuals harboring a variant of uncertain functional significance (VUS) in a homologous recombination (HR) gene, their risk of developing breast and ovarian cancer is unknown. Integral to the process of HR are BRCA1 and regulators of the central HR protein, RAD51, including BRCA2, PALB2, RAD51C and RAD51D. Due to advancements in sequencing technology and the continued expansion of cancer screening panels, the number of VUS identified in these genes has risen significantly. While variant analysis is improving, there remains a struggle to keep up with demand. Understanding the effects of an HR variant can aid in preventative care and is critical for developing an effective cancer treatment plan. In this dissertation, we functionally screened 27 RAD51C ovarian cancer VUS, identifying two HRD variants. Modeling these and other previously analyzed HRD RAD51C ovarian cancer variants in the newly published BCDX2 cryoEM structure, we found a functionally deficient cluster within the critical Walker B region. Our study of RAD51C also uncovered two active translational start sites located at amino acid 1 and amino acid 10. The resulting protein isoforms and the M1 and M10 patient derived VUS were assessed and found to be functionally similar in their HR capabilities but showed differences in expression and possible cell type specificity. In all, these studies broaden our understanding of RAD51C and how its dysfunction can promote disease progression and response to therapy. These data have the potential to aid in more efficacious pathogenicity classification and improve patient care.


Share

Citation/Export:
Social Networking:
Share |

Details

Item Type: University of Pittsburgh ETD
Status: Unpublished
Creators/Authors:
CreatorsEmailPitt UsernameORCID
Rein, Hayleyhlr42@pitt.eduhlr420000-0001-8939-3442
ETD Committee:
TitleMemberEmail AddressPitt UsernameORCID
Thesis AdvisorBernstein, Karakara.bernstein@pennmedicine.upenn.edu
Committee ChairOpresko, Patriciaopreskopl@upmc.edu
Committee MemberYanowitz, Judithyanowitzjl@mwri.magee.edu
Committee MemberAlder, Jonathanjalder@pitt.edu
Committee MemberNechemia-Arbely, Yaelarbelyy@upmc.edu
Date: 16 September 2024
Date Type: Publication
Defense Date: 29 August 2023
Approval Date: 16 September 2024
Submission Date: 2 October 2023
Access Restriction: 2 year -- Restrict access to University of Pittsburgh for a period of 2 years.
Number of Pages: 134
Institution: University of Pittsburgh
Schools and Programs: School of Medicine > Molecular Pharmacology
Degree: PhD - Doctor of Philosophy
Thesis Type: Doctoral Dissertation
Refereed: Yes
Uncontrolled Keywords: Homologous recombination deficient tumors; breast cancer; ovarian cancer; variant of unknown/uncertain significance; homologous recombination; BRCA1; BRCA2; PALB2; RAD51C; RAD51D; RAD51
Date Deposited: 16 Sep 2024 18:53
Last Modified: 16 Sep 2024 18:53
URI: http://d-scholarship.pitt.edu/id/eprint/45677

Available Versions of this Item

  • Functional Characterization of RAD51 Paralog Cancer Associated Variants of Unknown Significance. (deposited 16 Sep 2024 18:53) [Currently Displayed]

Metrics

Monthly Views for the past 3 years

Plum Analytics


Actions (login required)

View Item View Item